Latest News for: pseudomonas

Edit

Structural biology analysis of a Pseudomonas bacterial virus reveals a genome ejection motor

Science Daily 23 Oct 2024
DEV infects and lyses Pseudomonas aeruginosa bacteria, an opportunistic pathogen in cystic fibrosis ...
Edit

Structural biology analysis of a Pseudomonas bacterial virus reveals a genome ejection motor (The University of Alabama at Birmingham)

Public Technologies 21 Oct 2024
For example, a recent simple study of 92 showerheads and 36 toothbrushes from American bathrooms found more than 600 types of bacterial viruses, commonly called bacteriophages or phages ... Disclaimer.
Edit

EcoPhage LTD. Notice of Filing Pesticide Petition No. 4F9112 to Establish Exemption from the Requirement of a Tolerance for the Microbial Pesticides Bacteriophage active against Xanthomonas campestris pv. vesicatoria EcoPhage and Bacteriophage active against Pseudomonas syringae pv. tomato EcoPhage in or on All Food and Feed Commodities (The eRulemaking Program)

Public Technologies 27 Aug 2024
vesicatoria_EcoPhage and Bacteriophage active against Pseudomonas syringae pv ... vesicatoria_EcoPhage and Bacteriophage active against Pseudomonas syringae pv ... vesicatoria_EcoPhage and Bacteriophage active against Pseudomonas ... Pseudomonas syringae pv.
Edit

Armata Pharmaceuticals Announces Completion of Enrollment of Phase 2 Tailwind Study of Inhaled AP-PA02 in Non-Cystic Fibrosis Bronchiectasis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection

PR Newswire 11 Jul 2024
Armata is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens.
Edit

Study reveals rapid evolution and global spread of Pseudomonas aeruginosa

Phys Dot Org 05 Jul 2024
"From a clinical perspective, this study has revealed important information about Pseudomonas ... Aaron Weimann et al, Evolution and host-specific adaptation of Pseudomonas aeruginosa, Science (2024).
Edit

POSITIVE DATA FROM IN VIVO STUDY SHOWS SIGNIFICANT ANTIMICROBIAL ACTIVITY OF OCM™ AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) AND PSEUDOMONAS AERUGINOSA (PA) IN PORCINE WOUND MODEL

PR Newswire 20 May 2024
... (MRSA) aureus and pseudomonas aeruginosa (PA) bacterial counts and accelerated the formation of new tissue in MRSA-infected wounds, outperforming a comparator treatment and a control group.
Edit

Alarming superbug from deadly eyedrop outbreak has spread to dogs

Ars Technica 01 May 2024
/ A dog gets examined by veterinary technicians in Texas. (credit. Getty . Michael Paulsen) ... Those drops caused a deadly multi-state outbreak in humans over many months last year, with at least 81 people ultimately infected across 18 states ... Comments .
Edit

Pseudomonas Aeruginosa Infection Treatment Market Poised for Substantial Growth, Forecasted to Surpass USD 2,132.90 Million by 2031 | Marketresearch.biz Report

Pharmiweb 16 Apr 2024
Pseudomonas Aeruginosa Infection Treatment Market Overview. The Pseudomonas Aeruginosa Infection Treatment Market addresses the management of infections caused by the opportunistic pathogen Pseudomonas aeruginosa.
Edit

Global Pseudomonas Aeruginosa Treatment Market Report 2024-2030: How Allergan, Teva Pharma, Pfizer, Lupin Pharma, Merck, ...

Nasdaq Globe Newswire 12 Apr 2024
Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "Pseudomonas Aeruginosa Treatment Market Report. Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering ... .

Most Viewed

×